NCT00031889View on ClinicalTrials.gov

Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions
Prostate Cancer
Interventions
DRUG

Exemestane

Exemestane

DRUG

Exemestane+bicalutamide

Exemestane as in arm I and oral bicalutamide once daily

Trial Locations (12)

5001

Kantonspital Aarau, Aarau

CH-4031

University Hospital, Basel

CH-3010

Inselspital, Bern, Bern

CH-2500

Spitalzentrum Biel, Biel

CH-4101

Kantonsspital Bruderholz, Bruderholz

CH-7000

Ratisches Kantons und Regionalspital, Chur

Ch-1272

Clinique De Genolier, Genolier

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

CH-6900

Istituto Oncologico della Svizzera Italiana, Lugano

CH-6850

Ospedale Beata Vergine, Mendrisio

CH1951

Institut Central des Hopitaux Valaisans, Sion

CH-8091

Universitaetsspital, Zurich

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER

NCT00031889 - Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer | Biotech Hunter | Biotech Hunter